Evidence map›Paper›PMID 41438770›Full record

ReviewRSC advances2025

PLGA nanoparticles in otoprotection and inner ear regeneration: a new frontier in nanomedicine for hearing disorders.

Olusegun Oluwaseun Jimoh, Tolulope Ajuwon, Somtochukwu Samuel Okonkwo, Raymond Femi Awoyemi, Ibukunoluwa Olaosebikan, Olatayo Adedayo Olahanmi, Christopher Mbonu, Idris Oladimeji Junaid, Ikenna Odezuligbo, Kristinoba Olotu and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Olusegun Oluwaseun JimohDepartment of Pharmacology and Neuroscience, Southern Illinois University School of Medicine 801 N Rutledge Springfield Illinois 62702 USA godwinoluwaseun001@gmail.com.
Tolulope AjuwonSouth Dakota School of Mines and Technology USA.
Somtochukwu Samuel OkonkwoChemical and Bimolecular Engineering, University of Houston 4800 Calhoun Road Houston TX 77004 USA.
Raymond Femi AwoyemiDepartment of Chemistry, Mississippi State University MS 39762 USA.ORCID https://orcid.org/0000-0002-8154-3239
Ibukunoluwa OlaosebikanC. Eugene Bennett Department of Chemistry, West Virginia University 217 Clark Halll Morgantown WV 26506 USA.
Olatayo Adedayo OlahanmiDepartment of Chemistry, Middle Tennessee State University USA.
Christopher MbonuDepartment of Chemical Engineering & Material Science 1 Castle Point Terrace Hoboken New Jersey 07030 USA.
Idris Oladimeji JunaidQuality Assurance Department, Senior QA Specialist Catalent, 7555 Harmans Rd, Harmans MD 21077 USA idris.junaid@catalent.com.
Ikenna OdezuligboDepartment of Physics, Creighton University USA.
Kristinoba OlotuDepartment of Mechanical Engineering, University of Texas at Tyler USA.
Ikhazuagbe Hilary IfijenDepartment of Research Outreach, Rubber Research Institute of Nigeria Iyanomo Benin Nigeria ifijen.hilary@rrin.gov.ng larylans4u@yahoo.com.ORCID https://orcid.org/0000-0003-4165-5639

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sensorineural hearing loss (SNHL) remains a significant global health burden due to its irreversible nature and limited treatment options. Recent advances in nanotechnology have introduced new possibilities for targeted drug delivery to the inner ear, with poly(lactic-

Identifiers

PMID41438770
PMCPMC12721246

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.